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Currently,accuratediagnosisofbreastlesionsdependsonatripleassessmentapproachcomprisingclinical,imagingandpathologic
examinations. Fine needle aspiration cytology (FNAC) is widely adopted for the pathologic assessment because of its accurracy
and ease of use. While much has been written about the atypical and maliganant categories of FNAC diagnosis, little covers the
non-malignanat category which represents a sheer number in all FNAC cases. Moreover, any false-negative diagnosis of the non-
malignant cases may lead to missed diagnosis of cancer. This paper aims to discuss the issues of smear adequacy, the cytologic
features of benign breast lesions and the dilemma of a false-negative aspirate. Much has been suggested about the smear adequacy
criterion, including quantifying epithelial clusters, whereas others advocate basing adequacy on qualitative quantum of using
noncellular features of FNAC. Various benign lesions could be easily diagnosed at FNAC; however, they have cytologic features
overlapped with malignant lesions. False negativity of FNAC does occur; this could be caused by either “true” false-negative cases
attributed to suboptimal sampling technique, poor localization of the mass or nonpalpable lesions or “false” false-negative cases
due to interpretational errors. Though false-positive cases are less commonly found, they will also be discussed brieﬂy.
1.Introduction
Fine needle aspiration cytology (FNAC) has become popular
asavaluabletoolinpreoperativeassessmentofbreastmasses,
and it shows high accuracy, sensitivity, and speciﬁcity. It has
gained popularity due to its fast and easy approach, being
inexpensive, and can be performed with little complications.
To diﬀerentiate benign from malignant lesions is one of the
major goals of FNAC. In the evaluation of breast masses, the
time honored triple assessment combines clinical, radiologi-
cal, and pathological information, and FNAC, together with
core needle biopsy, is the initial pathological investigative
methods of choice. Much conﬁdence has been placed on
this approach for it can obviate standard excisional biopsy
when all three components of the triple test are conclusively
negative or positive [1]. Nevertheless, in FNAC of breast
lesions, there are instances where the diﬀerentiation of
benign and malignant is not possible. This problem arises
when paucity of specimen sampling is encountered or there
is a morphological overlap between benign and malignant
lesions (e.g., atypical hyperplasia and low-grade carcinoma
in situ, or in papillary lesions). As a result and to accommo-
date these problematic areas, cytological reporting categories
are used to objectively describe their features in cytological
terms and to incorporate the groups with uncertainties. The
most commonly used categorization is a ﬁve-tier system,
with categories ranging from insuﬃcient materials (C1),
benign (C2), atypical (C3), suspicious of malignancy (C4),
or frankly malignant (C5) (Table 1)[ 2]. This categorization
helps the cytopathologists to deﬁne the uncertain areas, and
the clinicians to oﬀer further investigation like excisional
biopsy judiciously. This categorization was initiated by the
national coordinating committee for breast screening and
the UK national breast screening program and serves as a
common dialect among all breast health care professionals
involved in breast management.2 Pathology Research International
Table 1: Cytology reporting categories∗.
C1 Inadequate
C2 Benign
C3 Atypia probably benign
C4 Suspicious of malignancy
C5 Malignant
∗From Diagnostic Cytopathology of the Breast by Zakhour and Wells [2].
Under this categorization, C1 is inadequate aspirate
smear due to hypocellularity, aspiration, smearing or stain-
ing errors. Most often, it is the degree of cellularity of the
epithelial cells that is inadequate [2]( Figure 1). The exact
deﬁnitionofwhatconstitutesaninadequateaspirateremains
an enigma, and this subjective issue is best determined by
the interpreter of the aspirate, whether or not a conﬁdent
diagnosis could be made basing on the quantity of the
materials aspirated. C2 category is for smears that are usually
cellular, showing the characteristic patterns of diﬀerent
benignlesions.Noatypicalormalignantfeaturesarepresent.
Usually duct conﬁgurations, myoepithelial cells, and bipolar
nuclei are visible. Inﬂammatory background is commonly
encountered. In contrast, C3 and C4 are the grey zones.
C3 presents the characteristics of a benign smear and
yet there are features that are not usually seen in clearly
benign specimens such as cellular crowding, pleomorphism,
and discohesion. C4 is reserved for aspirate where atypical
features are obvious but factors such as poor preservation,
hypocellularity, or components of a benign smear are
present, thus precluding a ﬁrm malignant diagnosis to be
made. This ambiguity shows the importance of correlation
with other disciplines. It also emphasizes not to stretch the
result of FNAC beyond the capabilities and experience of the
interpreter to reduce both positive and negative errors [2].
C5categoryconsistsofcellularaspiratewithevidentlymalig-
nant cytologic features. As much has been discussed on the
atypical,suspicious,andmalignantcategories,thispaperwill
be limited to the adequate (or inadequate) and benign cate-
goriestogetherwiththefalsenegativeandfalsepositivecases.
2. AdequateFNAC
The adequacy of FNAC is dependent on multiple factors.
The rate of inadequate aspiration ranges from 0.7% to 25.3%
(Table 2), and this is inﬂuenced by the nature of the lesion,
the available technology, and the experience and preference
of the operator [2]. It was reported that the nature of the
lesion was the most common cause of inadequacy of FNAC,
accounting for 68% of the inadequate aspirates, followed
by the experience of the aspirator that accounted for 32%
of the inadequacy rate [3]. During the procedure, patient’s
cooperation is valuable, and a well-informed patient with
good rapport with the operator for FNAC would greatly
facilitate the procedure and improve the outcome in terms
of adequacy. Thus, each procedure should be patterned
and restricted to clinically and radiologically appropriate
scenarios [2]. Some studies advocated that both aspirator
Figure 1: Photomicrograph of hypocellular smear, Pap, 10x. C1,
Hypocellular smear.
Table 2: Inadequate FNA.
Authors Inadequate cases
(%)
Total number
of cases
O’Neil et al. [24] 0.7% 697
Nguansangjam et al. [38] 4.2% 190
Rosa et al. [39] 8% 1583
Day et al. [40] 9% 831
Feichter et al. [41] 16.2% 1003
Zarbo et al. [6] 17% 13066
Park and Ham [37] 25.3% 699
and interpreter should ideally be the same, as the number
of inadequate aspirates was far lower and the accuracy of
diagnosis was higher when the same person aspirated and
reported on the specimens [2, 4, 5]. The mean frequency of
unsatisfactory aspirates by a nonpathologist was twice that
when performed by a pathologist [6].
Unanimous deﬁnition of specimen adequacy in breast
FNAC has not been reached so far. The National Cancer
Institute (NCI) deﬁnition of adequacy was one that led to
resolution of a problem presented by a lesion in a particular
patient’s breast [7]. This deﬁnition was somewhat vague,
being devoid of a quantiﬁable clause, but had the advantage
of being very ﬂexible and gave the aspirator the full mandate
in deciding whether the cytologic features of the aspirate
were consistent with the clinical ﬁndings and deemed
adequate [8]. This would be particularly useful when both
the aspirator, and interpreter of the sample were the same.
Most cytopathologists agree that a number of related
parameters are signiﬁcant determinants of the adequacy of
breast FNAC, and these include clinical and imaging ﬁnd-
ings, size of the lesion, aspiration characteristics, experience
of the aspirator, and the number of the needle passes [9].
Nevertheless, many authors considered epithelial cell clustersPathology Research International 3
Table 3: Benign FNA.
Authors Benign cases (%) Total number of cases
O’Neil et al. [24] 24% 697
Ishikawa et al. [25] 47.6% 382
Rosa et al. [39] 60% 1583
Feichter et al. [41] 68.1% 1003
Day et al. [40] 77.5% 831
as the most important adequacy criteria. Studies demon-
strated that an appropriate number of epithelial cell clusters
could be an important factor in lowering the false-negative
diagnosis rate in palpable and nonpalpable breast masses [9–
13].Itwasfurthersuggestedthatacut-oﬀofsixepithelialcell
clusters may provide a reasonable balance between reduction
of false-negative FNAC smears and an increase in the rate
of inadequate smears [13]. Since diagnosing malignancy
involves evaluation of the cytologic features of the epithelial
cells, quantiﬁcation of epithelial cells in the smears is most
likely helpful [9]. Other authors however, proposed not to
require a minimum number of ductal epithelial cells as
an adequacy criterion, and the assessment relied more on
the noncellular features of FNA such as conﬁdence and
experience of the clinician or operator with regard to needle
placement, resistance of the mass to the needle, and correla-
tionwiththeclinicalandphysicalﬁndings[8],thatis,usinga
triple assessment approach. Argument for this approach was
that if one was to apply a speciﬁc number of ductal epithelial
cell clusters [3–10], up to 35–40% of the true negative
FNAC using a nonquantitative method would become
unsatisfactory, forcing patients to undergo more expensive
and possibly unnecessary work ups [8]. Typical examples
would be in breast cysts, in which the aspirates usually yield
histiocytes without epithelial cells. Rendering an inadequate
diagnosis in an aspirate that collapsed a cyst yielding signif-
icant amount of serous ﬂuid would make correlation with
the clinical parameters diﬃcult. Similar situations would be
seen in postmastectomy scars with ﬁbrosis, in which the
hardened ﬁbrotic area gives very low yield, and labeling such
as inadequate may cause anxiety to the patients and prompt
unnecessary subsequent investigations or excisions.
In reality, the issue is not in choosing to which school of
thought should one aﬃliate in deﬁning an adequate smear. A
morepracticalapproachistoconsidertheresultsofthetriple
test and the appearance of the epithelial clusters.
3.Benign FNAC
The bulk of breast FNAC diagnoses are benign, accounting
for 24–77.5% of cases (Table 3). Fibrocystic changes present
a spectrum of histological features that may sometimes
be associated with calciﬁcation. Cystic changes represent a
commonﬁnding. Characteristically,thesize ofthecystvaries
in between consultation visits, giving the clinician further
hint on its benign nature, especially when accompanied by
imaging studies. In most situations, the aspirated cyst ﬂuid
may not be routinely submitted for cytologic evaluation,
Figure 2: Photomicrograph of cyst contents composed of scattered
macrophages and clusters of benign ductal cells, Pap, 4x. Cyst
contents: scattered macrophages and few clusters of benign ductal
cells.
except when the ﬂuid is blood stained, cloudy, or turbid
or when the masses remain uncollapsed and palpable after
the aspiration. Most of the time, the smears would only
show macrophages mixed with other inﬂammatory cells,
conﬁrming the cystic content nature of the lesion. Ductal
epithelial and myoepithelial cells are also commonly seen
in cyst aspirate, mostly as small balls and clusters mixed
with the macrophages (Figure 2). Apocrine cells lining cyst
cavity may exfoliate, showing the characteristic eosinophilic
cytoplasmandroundnucleiwithdistinctnucleoli.Theabove
ﬁndings of apocrine cells, macrophages, and ductal cells
are the characteristic features of a nonproliferative type of
ﬁbrocysticchanges,whichyieldsonlyscantymaterials.When
there is a signiﬁcant epithelial proliferative component,
sheets and tight clusters of cells are usually prominent. The
presence of atypia in these cellular clusters may be further
evaluated basing on cellular and nuclear spacing, multiple
nucleoli, and character of chromatin materials. When these
cytologic features are encountered, intraductal papilloma
and ﬁbroadenoma are some of the diﬀerentials that need to
be ruled out. Though cytologically indistinguishable from
proliferative ﬁbrocystic changes, intraductal papilloma is
oftenaccompaniedbyclinicalhistoryofnippledischargeand
a palpable subareolar mass.
Another potential source of confusion rises when there
is the presence of proteinaceous ﬂuid in the background,
being associated with epithelial cells that are large, with
enlarged nuclei, eosinophilic nucleoli, and vacuolated and
wispy cytoplasm. The nuclear features may appear worri-
some. Nevertheless, one should also be on the outlook for
lactational changes, and the appropriate history has to be
sought to avoid a false-positive diagnosis [2]. FNA plays
a signiﬁcant role when a discrete nodule appears during
pregnancyorlactation.Thissparesthepregnantpatientfrom
the pain and complications of excision.
In more ﬂorid examples, thickening of the wall due to
papillary apocrine change may cause papillary clusters with
the same cytoplasmic and nuclear details to be present [2].4 Pathology Research International
Figure 3: Photomicrograph of apocrine cells with granular cyto-
plasm and mild anisonucleosis, Pap, 10x. Apocrine cells: granular
cytoplasm and mild anisonucleosis.
Not all smears from cyst aspirate are easy to evaluate. Apoc-
rine cells, when degenerated will most often appear atypical
especially if it has progressed over time to the phase of
chromatin clumping with associated anisonucleosis [2], and
these could potentially be labeled as suspicious (Figure 3).
When there is infection or prior rupture of the cyst, the
aspirated ﬂuid may be turbid or milky. Such aspirates
often contain degenerated cells and debris in an abundant
background of inﬂammatory cells. In this situation, it needs
to be diﬀerentiated from the rare squamous carcinoma,
which may present with features akin to inﬂamed cyst.
Among the solid breast lesions, ﬁbroadenoma is most
common especially in women who are less than 40 years old.
The clinical presentation is very characteristic, and correct
clinical diagnosis can often be made. Radiologically, it is
described as a low density mass with well-deﬁned margins.
Calciﬁcation may not often be present in ﬁbroadenoma
especially in the young age group, but among older popu-
lation a popcorn calciﬁcation is characteristic [14]. Multiple
ﬁbroadenomas are seen in 15 to 20% of the cases [2].
FNAC diagnosis of ﬁbroadenoma is highly accurate.
Lopez-Ferrer reported a 79.3% predictive value out of
362 ﬁbroadenoma aspirates with most diagnostic errors
occurringintheolderagegroup[15].Cytologically,aspirates
are hypercellular with characteristic monolayer sheets of
benign-looking epithelial cells mixed with myoepithelial
cells. These sheets are often described as “staghorn”, having
antler-like conﬁguration on its edges (Figure 4). This pattern
reﬂectstheconﬁgurationofductsasobservedonhistological
sections [2, 16]. Cellular cohesiveness is often appreciated
in the aspirate smear. Accompanying the epithelial cells are
the ﬁbrillar stromal materials which may vary in cellularity
and sometimes show myxoid change (Figure 5). Commonly,
the background of the aspirate is composed of numerous
naked/bipolar nuclei (Figure 6). This is one of the character-
istic cytologic features of ﬁbroadenoma. The added presence
oflargenumberofbipolarnucleiinthebackgroundofsmear
Figure 4: Photomicrograph of hypercellular smear with monolay-
ered sheets of ductal cells in ﬁbroadenoma, Pap, 10x. Fibroade-
noma: hypercellular smear with monolayered sheets of ductal cells.
Figure 5: Photomicrograph of stromal fragments in ﬁbroadenoma,
H&E, 10x. Fibroadenoma: stromal fragments.
is a reliable feature in favor of ﬁbroadenoma [2]. There
are aspirates which may show less pronounced antler horns
but this may represent sample from ﬁbroadenoma with
pericanalicularpattern.Branchingofepithelialsheetsismore
common if the aspirated sample is from an intracanalicular
form (Figure 7). The commonly encountered cytological
features of ﬁbroadenoma are ﬁbromyxoid stroma, staghorn
clusters, and numerous single bare nuclei, being seen in
92.7%, 73.6%, and 73.6% of cases, respectively [17]. These
ﬁndings constitute the diagnostic triad for ﬁbroadenoma.
There are instances wherein the diagnosis of ﬁbroadenoma
on cytology is not straight forward. The absence of any
components of the diagnostic triad and low cellularity are
the common causes of pitfalls in missed cytodiagnosis of
ﬁbroadenoma [17]( Table 3). Giant cells are uncommonly
seen in ﬁbroadenomas (Figure 8). In the report of Kollur
and El Hag, it showed an increased incidence, being presentPathology Research International 5
Figure 6: Photomicrograph of numerous bipolar cells in ﬁbroade-
noma, H&E, 10x. Fibroadenoma: bipolar cells in the background.
in 31.8% of the aspirated cases [17]. These giant cells are
variable in appearance, were thought to be stromal in origin
[18, 19], and are of little prognostic signiﬁcance. Most series
reported the presence of these stromal giant cells being
present in ﬁbroepithelial lesions of the breast, but were
more common in phyllodes tumor than ﬁbroadenomas [18,
19]. Sometimes, giant cells may indicate an extra-tumoral
reactive process in the surrounding breast tissue which may
be due to palpation granuloma or fat necrosis [17]. It is a
known fact that ﬁbroadenoma is diﬃcult to distinguish from
phyllodestumorusingaspirationcytologybuttherearesome
features that are more characteristic to phyllodes tumors that
will support its diagnosis on cytology. A cellular aspirate
with numerous plump and spindly nuclei, pronounced of
hypercellularity of stromal fragments, and presence of atypia
are the key points that support a diagnosis of phyllodes
tumor over ﬁbroadenomas. However, these diﬀerentiating
featuresmaynotbepresentinallcases.Thepresenceofmore
stromal fragments over epithelial fragments (higher stromal
epithelial ratio) and the presence of single columnar cells
in the background are some of the “soft signs” reported for
the identiﬁcation of phyllodes tumor over ﬁbroadenoma. In
the extremely rare instance in which a malignant phyllodes
tumor is encountered, the sarcomatous spindle cells within
cellular stromal fragments may be deﬁnitive for the estab-
lishment of the diagnosis. Fibroadenomas also need to be
diﬀerentiated from papillomas, by virtue of the fact that the
latter show presence of small cell balls or clusters, with either
staghorn or papillary conﬁgurations in the smears.
On the whole, FNAC showed a high sensitivity of up
to 68–97% in ﬁbroadenomas [15, 17], and it has been
demonstrated that the overall cellularity, amount of bipolar
nuclei, amount and architectural of epithelium, apocrine
metaplasia, nuclear overlapping and pleomorphism, foam
cells, and stroma are signiﬁcant cytologic parameters in
distinguishing ﬁbroadenomas from papilloma, fat necrosis,
ﬁbrocystic changes, and duct ectasia [16].
Nipple discharge is one of the alarming complaints
that would prompt patients to seek clinical consults. This
represents, commonly, a papillary lesion involving one of
Figure 7: Photomicrograph of antler-horn conﬁguration of ductal
cells in ﬁbroadenoma, Pap, 10x. Fibroadenoma: antler-horn conﬁg-
uration.
Figure 8: Photomicrograph of giant cells in ﬁbroadenoma, H&E,
20x. Fibroadenoma: stromal giant cells.
the major lactiferous ducts [2]. Intraductal papillomas are
usually solitary and most often found in the subareolar
region. It is relatively common, accounting for 2.5% of all
benign breast excisions [16]. It is seen as a well-deﬁned
mass which radiologically presents as low-density soft tissue
mass with no surrounding architectural distortion or tissue
response. Calciﬁcation, when present, is usually of the
dystrophic and curvilinear type [2]. In addition, papillary
fronds reminiscent of staghorn clusters can also be seen in
papillomas. It was found that foam cells in association with
these fronds is one of the more speciﬁc features of diﬀer-
entiating papilloma from ﬁbroadenoma [2, 16]. Papillomas
in FNAC may cause diagnostic problems. The accuracy of
FNAC in diagnosing papillary lesions and diﬀerentiating
benign and malignant papillary lesions is low [20]. Among
the aspirates diagnosed as atypical, intraductal papilloma
represents about 6% [21]. For papillomas, the typical FNAC
picture of papillary fronds, cell balls, and columnar cells may
notallbeseenintheaspirate,whichmayalsobecomplicated6 Pathology Research International
Figure 9: Photomicrograph of papillary fronds in papilloma, Pap,
10x. Papilloma: papillary fronds.
Figure 10: Photomicrograph of cell balls with cytologic atypia in
papilloma, Pap, 20x. Papilloma: cell balls with cytologic atypia.
byahemorrhagicbackground(Figures9and10).Atsuchthe
cytologic picture may raise the possibility of a malignancy.
Problems also occur when the papillomas are complicated
by epithelial hyperplasia, hyalinization, or apocrine changes
as these may yield hypocellular to hypercellular smears
with pleomorphic cells showing prominent and background
necrotic debris [22, 23]. To date, there have been no well-
deﬁned cytological criteria to diﬀerentiate between benign
and malignant papillary lesions. Their signiﬁcant overlap in
terms of architecture and cytological atypia is the primary
reasons for not diﬀerentiating them cytologically [20, 21].
4. False-NegativeFNAC
FNAC has irrefutably and signiﬁcantly contributed to the
reduction of excisional biopsies in the assessment of breast
lesions, especially in the context of triple assessment [24].
Nevertheless, there still exists a signiﬁcant false negative
rate for FNAC, in the range of 1.2–10.6% (Table 4). These
may lead to missed/delayed diagnosis and treatment [25],
sometimes with adverse clinical outcome. This has become a
Table 4: False-negative FNA.
Authors False negative cases
(%)
Total number
of cases
Rosa et al. [39] 1.2% 1583
O’Malley et al. [12] 1.6% 1005
O’Neil et al. [24] 1.9% 697
Ishikawa et al. [25] 2.2% 382
Arisio et al. [29] 3.9% 1601
Day et al. [40] 5.4% 831
Feichter et al. [41] 9% 1003
Park and Ham [37] 10% 699
major concern, prompting, on the side of the laboratory and
pathologist, are-evaluationoftheadequacylimitation, refer-
ral system, and processing techniques. Previous studies have
demonstrated that the sensitivity, speciﬁcity, and accuracy of
breast FNAC all ranged from 77% to 100% [24, 26–29].
Theunderlyingcausesforfalsenegativitycanbegrouped
into diagnostic errors and true false negative factors. Diag-
nostic errors can be attributed to lack of training, overload
of cases, and miscorrelation with the patient’s clinical and
radiologic ﬁndings [6]. In the true false negative factors, the
denominators are poor sampling technique, mislocalization
of the tumor, or the presence of a well-deﬁned tumor
demonstrating minimal atypia [29, 30]. The widespread
adoption of breast screening and advances in imaging
techniques also resulted in the detection of small lesions, and
understandably, FNAC of these small lesions has a signiﬁcant
risk of missing these lesions, leading to potentially false-
negative results.
Nonpalpable lesions constitute a speciﬁc category of
screen detected lesion. In one study, 21% of false negative
breast FNAC was due to nonpalpable tumors [31]. The
main problem associated with FNAC of nonpalpable lesions
was the variable but sometimes unacceptably high rate
[32] of inadequacy. An inadequacy rate as high as 34–
58% had previously been reported [33, 34], and the lowest
reportedinadequacyratewasaround10%[35,36].Attaining
adequacy in the aspirates of these nonpalpable lesions poses
greater challenge because of their small sizes in many cases,
as well as the presence of ﬁbrotic component. Nowadays,
management of these lesions always involves CT or ultra-
sound guidance to better deﬁne and localize the lesion upon
aspiration. Apart from tumor size, tumor grade was also an
important risk factor for false-negative FNAC (Table 5). In
Bulgaresi’s report of false-negative FNAC reporting, 24.3%
were those from special types of tumor, 39% of which
were low grade tumors [31]. The resemblance of lobular
carcinoma to lymphocytes and its subtle cytologic atypia
are well-known diagnostic problems. Ductal carcinoma, not
otherwise speciﬁed (NOS) subtype, accounted for 2/3 of the
cases false-negative cases in another series [37]. As a result,
nonpalpable lesions constitute a speciﬁc “blind area” not
amenable to FNAC, indeed most authors would recommend
core needle biopsy for the work up of such lesions [32].Pathology Research International 7
Table 5: Surgical followup in false-negative cases∗.
Follow up tissue diagnosis Number/percentage of cases
Atypical ductal hyperplasia 1 (5%)
Ductal carcinoma in situ 3 (16%)
Cribriform carcinoma 1 (5%)
Metaplastic carcinoma 1 (5%)
Inﬁltrating lobular carcinoma 6 (32%)
Inﬁltrating ductal carcinoma 7 (37%)
Total cases 19
∗Rosa [39]. The value of ﬁne needle aspiration biopsy in the diagnosis and
prognostic assessment of palpable breast lesions.
Table 6: False-positive FNA.
Authors False negative cases
(%)
Total number
of cases
Rosa et al. [39] 0% 1583
Day et al. [40] 0% 831
Arisio et al. [29] 0.3% 1601
Feichter et al. [41] 0.5% 1003
Park and Ham [37] 1% 699
Ishikawa et al. [25] 2% 382
5.False-PositiveFNAC
False-positive diagnosis in aspiration cytology is signiﬁcantly
lower in incidence compared to false-negative cases. From
the previous reports, false-positive cases range from 0% to
2% (Table 6), in most studies reporting a 100% positive pre-
dictive value. Among the reported cases, the common lesion
givingafalse-positiveaspirateisductalhyperplasiaorlobular
hyperplasia. This ﬁnding is also in consonance with previous
reports that ﬁbrocystic changes and pregnancy-related breast
massesaccountforfalse-positiveﬁndings[25].Inmostofthe
accounted cases, radiologic ﬁndings are mostly indetermi-
nate for breast cancer, requiring conﬁrmation by histology.
6. Summary
FNAC is an essential component in the preoperative man-
agement of breast lesions. Its accuracy, ease of use, and aﬀo-
rdability are factors that cause its popularity. The advent
of imaging technology together with the clinical expertise
of the clinician contributed to its increased sensitivity. The
adequacy of smears is inﬂuenced by the nature of the
lesion, experience of the aspirator, and access to the available
imaging modality. An adequate smear can be deﬁned by
either quantitative or qualitative means, with advocates for
either approach. Nevertheless, the operators’ experience and
conﬁdence in correlating with the clinical and radiologic
ﬁndings, the cellularity of smears, and the aspiration tech-
nique are always helpful. Exceptions occur in cystic and
ﬁbrotic lesions that are inevitably hypocellular. Degenerative
changes would render the smear to be diﬃcult to interpret.
Benign breast lesions are usually easy to diagnose when their
characteristic cytologic patterns are obvious. Hypocellular-
ity,degeneratedapocrinecells,necrosis,andepithelialhyper-
plasia are some of the factors that may be encountered in
evaluatingadiﬃcultsmear,mimicking atypicalormalignant
lesions. The false-negative cases in breast FNAC, although
few, are commonly due to poor sampling technique, poor
tumor localization, and the presence of a well-diﬀerentiated
histology of the tumor. Small tumor size and nonpalpable
breast lesions are also commonly associated with false-
negative and aspirate inadequacy. Thus in the interpretation
of breast FNAC, all these factors should be considered before
a benign diagnosis is being rendered.
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